Royal Bank of Canada’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $285M | Buy |
3,801,815
+2,683,018
| +240% | +$212M | 0.05% | 328 |
|
|
2025
Q4 | $88.5M | Sell |
1,118,797
-107,827
| -9% | -$8.12M | 0.01% | 699 |
|
|
2025
Q3 | $80.2M | Buy |
1,226,624
+426,712
| +53% | +$20.8M | 0.01% | 794 |
|
|
2025
Q2 | $31.6M | Buy |
799,912
+183,831
| +30% | +$6.02M | 0.01% | 1201 |
|
|
2025
Q1 | $18.6M | Sell |
616,081
-27,111
| -4% | -$888K | ﹤0.01% | 1355 |
|
|
2024
Q4 | $22.5M | Sell |
643,192
-26,957
| -4% | -$1.01M | ﹤0.01% | 1266 |
|
|
2024
Q3 | $26.8M | Sell |
670,149
-8,211
| -1% | -$382K | 0.01% | 1165 |
|
|
2024
Q2 | $32.3M | Sell |
678,360
-53,877
| -7% | -$2.21M | 0.01% | 995 |
|
|
2024
Q1 | $31.7M | Sell |
732,237
-42,009
| -5% | -$2M | 0.01% | 988 |
|
|
2023
Q4 | $39.2M | Buy |
774,246
+110,802
| +17% | +$5.31M | 0.01% | 893 |
|
|
2023
Q3 | $30.1M | Buy |
663,444
+86,306
| +15% | +$3.56M | 0.01% | 941 |
|
|
2023
Q2 | $23.7M | Buy |
577,138
+81,181
| +16% | +$3.12M | 0.01% | 1074 |
|
|
2023
Q1 | $17.7M | Sell |
495,957
-10,888
| -2% | -$409K | 0.01% | 1209 |
|
|
2022
Q4 | $19.1M | Buy |
506,845
+70,021
| +16% | +$2.95M | 0.01% | 1178 |
|
|
2022
Q3 | $19.3M | Buy |
436,824
+8,401
| +2% | +$354K | 0.01% | 1089 |
|
|
2022
Q2 | $15.9M | Sell |
428,423
-16,079
| -4% | -$606K | ﹤0.01% | 1256 |
|
|
2022
Q1 | $16.5M | Sell |
444,502
-36,146
| -8% | -$1.18M | ﹤0.01% | 1369 |
|
|
2021
Q4 | $14.6M | Sell |
480,648
-8,913
| -2% | -$281K | ﹤0.01% | 1610 |
|
|
2021
Q3 | $16.4M | Buy |
489,561
+4,595
| +0.9% | +$173K | ﹤0.01% | 1479 |
|
|
2021
Q2 | $19.3M | Buy |
484,966
+325,352
| +204% | +$12.7M | 0.01% | 1370 |
|
|
2021
Q1 | $7.18M | Buy |
159,614
+8,927
| +6% | +$498K | ﹤0.01% | 1984 |
|
|
2020
Q4 | $8.52M | Sell |
150,687
-3,815
| -2% | -$190K | ﹤0.01% | 1833 |
|
|
2020
Q3 | $7.33M | Sell |
154,502
-2,328
| -1% | -$129K | ﹤0.01% | 1755 |
|
|
2020
Q2 | $9.25M | Sell |
156,830
-3,822
| -2% | -$213K | ﹤0.01% | 1534 |
|
|
2020
Q1 | $7.59M | Sell |
160,652
-31,819
| -17% | -$1.77M | ﹤0.01% | 1529 |
|
|
2019
Q4 | $11.6M | Sell |
192,471
-11,394
| -6% | -$679K | ﹤0.01% | 1527 |
|
|
2019
Q3 | $12.2M | Sell |
203,865
-12,357
| -6% | -$805K | ﹤0.01% | 1414 |
|
|
2019
Q2 | $13.9M | Buy |
216,222
+29,545
| +16% | +$2.09M | 0.01% | 1330 |
|
|
2019
Q1 | $15.2M | Sell |
186,677
-1,159
| -0.6% | -$74.8K | 0.01% | 1244 |
|
|
2018
Q4 | $10.2M | Sell |
187,836
-271,791
| -59% | -$13.9M | ﹤0.01% | 1454 |
|
|
2018
Q3 | $23.7M | Sell |
459,627
-5,789
| -1% | -$272K | 0.01% | 1020 |
|
|
2018
Q2 | $19.4M | Sell |
465,416
-19,466
| -4% | -$863K | 0.01% | 1094 |
|
|
2018
Q1 | $21.4M | Buy |
484,882
+69,457
| +17% | +$3.53M | 0.01% | 1053 |
|
|
2017
Q4 | $20.9M | Buy |
415,425
+244,281
| +143% | +$13.4M | 0.01% | 1114 |
|
|
2017
Q3 | $8.68M | Sell |
171,144
-4,866
| -3% | -$255K | ﹤0.01% | 1632 |
|
|
2017
Q2 | $8.95M | Buy |
176,010
+80,290
| +84% | +$3.74M | ﹤0.01% | 1573 |
|
|
2017
Q1 | $3.85M | Sell |
95,720
-9,416
| -9% | -$423K | ﹤0.01% | 2097 |
|
|
2016
Q4 | $5.03M | Sell |
105,136
-18,848
| -15% | -$746K | ﹤0.01% | 1947 |
|
|
2016
Q3 | $4.54M | Sell |
123,984
-43,591
| -26% | -$1.36M | ﹤0.01% | 1978 |
|
|
2016
Q2 | $3.9M | Sell |
167,575
-10,387
| -6% | -$335K | ﹤0.01% | 2053 |
|
|
2016
Q1 | $7.21M | Sell |
177,962
-33,959
| -16% | -$1.38M | ﹤0.01% | 1576 |
|
|
2015
Q4 | $13.1M | Buy |
211,921
+17,235
| +9% | +$930K | 0.01% | 1256 |
|
|
2015
Q3 | $7.87M | Sell |
194,686
-169,875
| -47% | -$8.79M | 0.01% | 1306 |
|
|
2015
Q2 | $21M | Sell |
364,561
-88,380
| -20% | -$5.62M | 0.01% | 793 |
|
|
2015
Q1 | $28.8M | Sell |
452,941
-74,091
| -14% | -$5.03M | 0.02% | 625 |
|
|
2014
Q4 | $32.5M | Sell |
527,032
-62,058
| -11% | -$3.06M | 0.02% | 601 |
|
|
2014
Q3 | $22.9M | Buy |
589,090
+428,355
| +266% | +$15.2M | 0.02% | 729 |
|
|
2014
Q2 | $5.54M | Buy |
160,735
+59,749
| +59% | +$1.88M | ﹤0.01% | 1579 |
|
|
2014
Q1 | $4.36M | Buy |
100,986
+40,020
| +66% | +$1.94M | ﹤0.01% | 1668 |
|
|
2013
Q4 | $2.43M | Buy |
60,966
+31,143
| +104% | +$1.11M | ﹤0.01% | 2148 |
|
|
2013
Q3 | $1.12M | Buy |
29,823
+6,418
| +27% | +$192K | ﹤0.01% | 2665 |
|
|
2013
Q2 | $629K | Buy |
+23,405
| New | +$498K | ﹤0.01% | 2945 |
|
Other funds holding IONS
VPM
VCM
Royal Bank of Canada's IONS Position: Q1 2026 in Review
Royal Bank of Canada increased its Ionis Pharmaceuticals (IONS) stake by 240% in Q1 2026, buying an estimated $212M and bringing the position to 3,801,815 shares worth $285M. The position accounts for 0.05% of the portfolio, ranked #328.
Royal Bank of Canada first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Royal Bank of Canada held 3,801,815 shares of Ionis Pharmaceuticals worth $285M as of Q1 2026.
- Royal Bank of Canada bought 2,683,018 Ionis Pharmaceuticals shares in Q1 2026, an estimated $212M.
- Ionis Pharmaceuticals made up 0.05% of Royal Bank of Canada's portfolio in Q1 2026, its #328 holding.
- Royal Bank of Canada first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.